Pharmaceutical wholesale · Infusion drugs
Starting January 1, 2027, Medicare is lowering reimbursement for 340B acquired drugs ~34%, from ASP+6% to ASP-28%. Hospitals need a sustainable solution.
CMS-estimated 2027 cut to 340B hospital drug payments
340B-acquired drug purchases that need a better source
Hospital margin when bought at ASP, before sequestration
The hospital orders from Parity Rx. We're the bill-to party on the invoice.
The manufacturer or its logistics partner ships straight to the hospital. We never hold the stock.
We invoice at ASP. The hospital bills Medicare at ASP + 6% and keeps a positive margin.
A fast way to cushion the 2027 340B cut: buy affected infusion drugs at ASP and stop administering them at a loss.
A licensed, DSCSA-compliant channel that drop-ships your branded products, with no new warehouse or cold-chain build-out.